AzTrials
AzTrials

Reliability of the Ultrasound in Percutaneous TracheostomyNCT02855749

Ultrasound Guided Percutaneous Tracheostomy

A study testing ultrasound-guided percutaneous tracheostomy in people with Reliability of the Ultrasound in Percutaneous Tracheostomy, run by Erzincan University.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Use of the ultrasound before, during and after percutaneous tracheostomy allows us great advantages; anatomy of the pre and paratracheal region and displaying potential aberrant vessels, and so the needle and dilator to move away from risk areas and ensure the prevention of possible vascular complications. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
ultrasound-guided percutaneous tracheostomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
No sites listed yet
Study dates
Aug 2016to Dec 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • hospitalized patients in intensive care
  • the decision to open percutaneous tracheostomy
  • over 18 years

Who cannot join

  • under 18 years
  • Patients with high or unstable intracranial pressure
  • Patients with severe coagulation disorders
  • Patients attached collar
  • hemodynamically unstable patients, despite the use of high doses of vasoactive drugs
  • patients with infections in tracheostomy area

About this study

Official title: Comparison of 3 Techniques for Percutaneous Tracheostomy : Traditional Marking Technique, Ultrasonography Guided Long Axis Approach and Short Axis Approach

Use of the ultrasound before, during and after percutaneous tracheostomy allows us great advantages; anatomy of the pre and paratracheal region and displaying potential aberrant vessels, and so the needle and dilator to move away from risk areas and ensure the prevention of possible vascular complications. Measuring the distance from the skin into the trachea can be done and this allows us to choose the average size tracheostomy tube.

The aim of this study, In the process of applying percutaneous tracheostomy, to compare the reliability of the traditional landmark method, ultrasound-guided long axis in plane application and ultrasound-guided short axis out of plane application.

Being tested
ultrasound-guided percutaneous tracheostomy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ultrasound-guided percutaneous tracheostomyProcedure or surgery

    to compare the reliability of the traditional landmark method, ultrasound-guided long axis in plane applications and ultrasound-guided short-axis out of plane application in the implementation process percutaneous tracheostomy

Study groups in NCT02855749
Study groupRoleWhat they receive
landmark groupNo interventionpercutaneous tracheostomy with traditional landmark technique
ultrasound-guided long axis groupActive comparatorpercutaneous tracheostomy will be implemented In the real-time ultrasound-guided in plane technique
Receives: Procedure: ultrasound-guided percutaneous tracheostomy
ultrasound-guided short axis groupActive comparatorpercutaneous tracheostomy will be implemented In the real-time ultrasound-guided out of plane technique
Receives: Procedure: ultrasound-guided percutaneous tracheostomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The success of the first application

    Measured: ten minute

  2. successful tube placement rate

    Measured: fifteen minüte

  3. Complications during the procedure

    Measured: one month

Secondary outcomes (3)
  1. The number of puncture

    Measured: ten minute

  2. total tracheostomy application time

    Measured: fifteen minute

  3. Early and late complications after the process

    Measured: one month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Aug 2016 (estimated)
  2. Study startAug 2016
  3. Primary completionNov 2016
  4. Study completionDec 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02855749
Sponsor's protocol ID
ERZINCAN UNIVERSITY 2
Status last verified
Jan 2017
First submitted
31 Jul 2016
Last updated
31 Jan 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Publications

  • Delaney A, Bagshaw SM, Nalos M. Percutaneous dilatational tracheostomy versus surgical tracheostomy in critically ill patients: a systematic review and meta-analysis. Crit Care. 2006;10(2):R55. doi: 10.1186/cc4887.

    PubMed 16606435
  • Cheung NH, Napolitano LM. Tracheostomy: epidemiology, indications, timing, technique, and outcomes. Respir Care. 2014 Jun;59(6):895-915; discussion 916-9. doi: 10.4187/respcare.02971.

    PubMed 24891198
  • Simon M, Metschke M, Braune SA, Puschel K, Kluge S. Death after percutaneous dilatational tracheostomy: a systematic review and analysis of risk factors. Crit Care. 2013 Oct 29;17(5):R258. doi: 10.1186/cc13085.

    PubMed 24168826
  • McCormick B, Manara AR. Mortality from percutaneous dilatational tracheostomy. A report of three cases. Anaesthesia. 2005 May;60(5):490-5. doi: 10.1111/j.1365-2044.2005.04137.x.

    PubMed 15819770
  • Flint AC, Midde R, Rao VA, Lasman TE, Ho PT. Bedside ultrasound screening for pretracheal vascular structures may minimize the risks of percutaneous dilatational tracheostomy. Neurocrit Care. 2009 Dec;11(3):372-6. doi: 10.1007/s12028-009-9259-z. Epub 2009 Aug 13.

    PubMed 19680824
  • Rudas M. The role of ultrasound in percutaneous dilatational tracheostomy. Australas J Ultrasound Med. 2012 Nov;15(4):143-148. doi: 10.1002/j.2205-0140.2012.tb00197.x. Epub 2015 Dec 31.

    PubMed 28191160
  • Chacko J, Nikahat J, Gagan B, Umesh K, Ramanathan M. Real-time ultrasound-guided percutaneous dilatational tracheostomy. Intensive Care Med. 2012 May;38(5):920-1. doi: 10.1007/s00134-012-2514-3. Epub 2012 Feb 17. No abstract available.

    PubMed 22349428
  • Rajajee V, Fletcher JJ, Rochlen LR, Jacobs TL. Real-time ultrasound-guided percutaneous dilatational tracheostomy: a feasibility study. Crit Care. 2011;15(1):R67. doi: 10.1186/cc10047. Epub 2011 Feb 22.

    PubMed 21342494
  • Kupeli I, Nalbant RA. Comparison of 3 techniques in percutaneous tracheostomy: Traditional landmark technique; ultrasonography-guided long-axis approach; and short-axis approach - Randomised controlled study. Anaesth Crit Care Pain Med. 2018 Dec;37(6):533-538. doi: 10.1016/j.accpm.2017.11.011. Epub 2017 Dec 7.

    PubMed 29225012

Questions about this trial

What is this clinical trial studying?

A study testing ultrasound-guided percutaneous tracheostomy in people with Reliability of the Ultrasound in Percutaneous Tracheostomy, run by Erzincan University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Jan 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The success of the first application (time frame: ten minute). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02855749, which also lists 9 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jan 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in